| Magnetotherapy. | |
| | |
MedLine Citation:
|
PMID: 19029874 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Since antiquity, the phenomenon of magnetism has been known, and it has been tried for therapeutic purposes. Through history, people have made use of both natural sources of magnetic fields (magnetic iron ore) and artificial ones (magnets, electromagnets). It was as late as the 19th century that we started to produce time-varying magnetic fields, making numerous observations about its impact on humans, the nervous system included. A majority of these observations were cognitive in nature. There are, however, studies aimed at assessing the therapeutic results of the influence of magnetic fields, particularly of low frequencies. In terms of magnetotherapy with the use of a low-induction magnetic field, there are serious doubts concerning its effectiveness in general, including therapy for mental disorders. The year 1985 witnessed the introduction of transcranial magnetic stimulation (TMS) into medical practice as a diagnostic tool in neurology as well as in basic neurophysiologic and neuropsychological investigations. The 1990s began the epoch of investigations into possible applications of TMS in therapy of mental disorders, particularly depression. This work presents critical remarks and limitations of TMS, such as findings that its effectiveness is not particularly high. The traditional fixed stimulation of a definite area of the patient's head may lead to irritation of structures that, in a specific patient, may not be responsible for the symptoms of depression. The effectiveness could be improved only with the use of neuronavigation and prestimulation via functional neuroimaging diagnostics of the brain, which, however, would make TMS expensive and less practical. |
| | |
Authors:
|
Tomasz Zyss |
Related Documents
:
|
19453164 - Detecting the magnetic response of iron oxide capped organosilane nanostructures using ... 20614054 - Hyperpolarized 19f-mri: parahydrogen-induced polarization and field variation enable 19... 11816614 - Magnetic resonance imaging safety: implications for cardiovascular patients. 18521844 - The effects of inverter magnetic fields on early seed germination of mung beans. 18162354 - Clinical advantages of 3.0 t mri over 1.5 t. 3155774 - Polymorphism of the c3b/c4b receptor (cr1): characterization of a fourth allele. |
Publication Detail:
|
Type: Historical Article; Journal Article; Review |
Journal Detail:
|
Title: Neuro endocrinology letters Volume: 29 Suppl 1 ISSN: 0172-780X ISO Abbreviation: Neuro Endocrinol. Lett. Publication Date: 2008 Nov |
Date Detail:
|
Created Date: 2009-04-16 Completed Date: 2009-05-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8008373 Medline TA: Neuro Endocrinol Lett Country: Sweden |
Other Details:
|
Languages: eng Pagination: 161-201 Citation Subset: IM |
Affiliation:
|
Department of Psychiatry, University Hospital in Kraków Collegium Medicum Jagellonian University, Cracow, Poland. mzzyss@cyf-kr.edu.pl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Clinical Trials as Topic Electroconvulsive Therapy Ferrosoferric Oxide / therapeutic use History of Medicine History, 15th Century History, 16th Century History, 17th Century History, 18th Century History, 19th Century History, 20th Century History, 21st Century History, Ancient History, Medieval Humans Magnetic Field Therapy* / history, methods Mental Disorders / therapy* Time Factors Transcranial Magnetic Stimulation |
| Chemical | |
Reg. No./Substance:
|
1317-61-9/Ferrosoferric Oxide |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Psychosurgery: the past and present of ablation procedures.
Next Document: Herbal drug treatment.